Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-19 of 19
Keywords: Diabetic cardiomyopathy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2023) 137 (16): 1297–1309.
Published: 22 August 2023
...Mengwen Wang; Yujian Liu; Lei Dai; Xiaodan Zhong; Wenjun Zhang; Yang Xie; Hesong Zeng; Hongjie Wang Diabetic cardiomyopathy (DCM) is a chronic metabolic disease with few effective therapeutic options. Immunoproteasome is an inducible proteasome that plays an important role in the regulation of many...
Includes: Supplementary data
Articles
Cardioprotective and anti-inflammatory effects of Caveolin 1 in experimental diabetic cardiomyopathy
Wenyan Gong, Qibin Jiao, Jinghua Yuan, Hui Luo, Yingying Liu, Yuanyuan Zhang, Zhen Chen, Xiaoling Xu, Lin Bai, Xingwei Zhang
Journal:
Clinical Science
Clin Sci (Lond) (2023) 137 (6): 511–525.
Published: 24 March 2023
... metabolism disorders, inflammation, diabetes, and cardiovascular disease. However, there have been no reports linking Cav1 to diabetic cardiomyopathy (DCM). In the present study, we established a relationship between Cav1 and the development of DCM. We found that compared with Cav1 +/+ mice, Cav1...
Articles
Dajun Chai, Xiaoyan Lin, Qiaowen Zheng, Changsheng Xu, Hong Xie, Qinyun Ruan, Jinxiu Lin, Jie Liu, Jinzhang Zeng
Journal:
Clinical Science
Clin Sci (Lond) (2020) 134 (6): 609–628.
Published: 24 March 2020
... development and has been implicated in cardiovascular diseases. In the present study, we investigated the effects of RXR agonist treatment on streptozotocin (STZ)-induced diabetic cardiomyopathy (DCM) and the underlying mechanism. Sprague–Dawley (SD) rats induced by STZ injection were treated with either RXR...
Includes: Supplementary data
Articles
Mei Xue, Ting Li, Yue Wang, Yunpeng Chang, Ying Cheng, Yunhong Lu, Xiangyang Liu, Linxin Xu, Xiaoyu Li, Xiaochen Yu, Bei Sun, Liming Chen
Journal:
Clinical Science
Clin Sci (Lond) (2019) 133 (15): 1705–1720.
Published: 02 August 2019
...Mei Xue; Ting Li; Yue Wang; Yunpeng Chang; Ying Cheng; Yunhong Lu; Xiangyang Liu; Linxin Xu; Xiaoyu Li; Xiaochen Yu; Bei Sun; Liming Chen Cardiovascular complications contribute to the major mortality and morbidity in type 2 diabetes. Diabetic cardiomyopathy (DCM) is increasingly recognized...
Includes: Supplementary data
Articles
Fan Wu, Baile Wang, Saisai Zhang, Lihua Shi, Yanfang Wang, Rongrong Xiong, Xuebo Pan, Fanghua Gong, Xiaokun Li, Zhuofeng Lin
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (15): 1877–1893.
Published: 07 July 2017
...Fan Wu; Baile Wang; Saisai Zhang; Lihua Shi; Yanfang Wang; Rongrong Xiong; Xuebo Pan; Fanghua Gong; Xiaokun Li; Zhuofeng Lin The aim of the present study is to explore the molecular mechanism of fibroblast growth factor 21 (FGF21) in protecting against diabetic cardiomyopathy (DCM). Streptozotocin...
Includes: Supplementary data
Articles
Zheng Xu, Qian Tong, Zhiguo Zhang, Shudong Wang, Yang Zheng, Qiuju Liu, Ling-bo Qian, Shao-yu Chen, Jian Sun, Lu Cai
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (15): 1841–1857.
Published: 05 July 2017
...Zheng Xu; Qian Tong; Zhiguo Zhang; Shudong Wang; Yang Zheng; Qiuju Liu; Ling-bo Qian; Shao-yu Chen; Jian Sun; Lu Cai Inhibition of total histone deacetylases (HDACs) was phenomenally associated with the prevention of diabetic cardiomyopathy (DCM). However, which specific HDAC plays the key role...
Articles
Darnel Prakoso, Miles J. De Blasio, Chengxue Qin, Sarah Rosli, Helen Kiriazis, Hongwei Qian, Xiao-Jun Du, Kate L. Weeks, Paul Gregorevic, Julie R. McMullen, Rebecca H. Ritchie
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (12): 1345–1360.
Published: 07 June 2017
... by delayed intervention with rAAV6-caPI3K. Hence, our demonstration that cardiac-targeted PI3K (p110α) gene therapy limits diabetes-induced up-regulation of NADPH oxidase and cardiac remodelling suggests new insights into promising approaches for the treatment of diabetic cardiomyopathy, at a clinically...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (10): 897–915.
Published: 04 May 2017
...Mitchel Tate; David J. Grieve; Rebecca H. Ritchie Diabetes increases the risk of heart failure approximately 2.5-fold, independent of coronary artery disease and other comorbidities. This process, termed diabetic cardiomyopathy, is characterized by initial impairment of left ventricular (LV...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (17): 1511–1521.
Published: 18 July 2016
...Tao Bai; Fan Wang; Yang Zheng; Qiangrong Liang; Yuehui Wang; Jian Kong; Lu Cai Diabetic cardiomyopathy (DCM) is one of the major cardiovascular complications in diabetes that increase the mortality of diabetic patients. Mechanisms underlying DCM have not been fully elucidated, hindering targeted...
Articles
Jingjing Zhang, Yanli Cheng, Junlian Gu, Shudong Wang, Shanshan Zhou, Yuehui Wang, Yi Tan, Wenke Feng, Yaowen Fu, Nicholas Mellen, Rui Cheng, Jianxing Ma, Chi Zhang, Zhanquan Li, Lu Cai
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (8): 625–641.
Published: 08 March 2016
...), and with the approval of the Institutional Animal Care and Use Committee of the University of Louisville. autophagy diabetic cardiomyopathy FGF21-knockout PPARα agonist (fibrate) Sirt1 • FF as a PPARα agonist has been used clinically to lower lipid levels for many years. We tested for the first time...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (5): 325–335.
Published: 13 November 2014
...Xiang Zhou; Guoyin An; Xiang Lu There is growing evidence that H 2 S has beneficial effects in treatment of various cardiovascular diseases. However, it remains unclear whether H 2 S can attenuate the development of diabetic cardiomyopathy (DCM). The present study was designed to investigate...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (5): 321–323.
Published: 13 November 2014
... in the cardiovascular system which possesses multifactorial effects on various intracellular signalling pathways. The proven cardioprotective and vasodilator activities of H 2 S warrant a detailed investigation into its role in diabetic cardiomyopathy. In the present issue of Clinical Science , Zhou et al. demonstrate...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (7): 471–482.
Published: 06 December 2013
.... Correspondence: Dr Gavin Y. Oudit (email [email protected] ). 1 7 2013 12 9 2013 2 10 2013 © The Authors Journal compilation © 2014 Biochemical Society 2014 angiotensin-(1–7) angiotensin-converting enzyme 2 (ACE2) diabetes diabetic cardiomyopathy vascular complication...
Articles
Candice M. Thomas, Qian Chen Yong, Rachid Seqqat, Niketa Chandel, David L. Feldman, Kenneth M. Baker, Rajesh Kumar
Journal:
Clinical Science
Clin Sci (Lond) (2013) 124 (8): 529–545.
Published: 08 January 2013
... (angiotensin receptor blockers) or ACEis (angiotensin-converting enzyme inhibitors). In the present study, we determined whether renin inhibition is more effective at preventing diabetic cardiomyopathy than an ARB or ACEi. Diabetes was induced in adult mice for 10 weeks by STZ (streptozotocin). Diabetic mice...
Includes: Supplementary data
Articles
Chris Tikellis, Raelene Pickering, Despina Tsorotes, Xiao-Jun Du, Helen Kiriazis, Thu-Phuc Nguyen-Huu, Geoffrey A. Head, Mark E. Cooper, Merlin C. Thomas
Journal:
Clinical Science
Clin Sci (Lond) (2012) 123 (8): 519–529.
Published: 03 July 2012
... The Authors Journal compilation © 2012 Biochemical Society 2012 angiotensin angiotensin-converting enzyme 2 diabetes diabetic cardiomyopathy renin–angiotensin system Paraffin serial sections 4-μm thick were prepared from 4% PFA (paraformaldehyde)-fixed paraffin-embedded mouse aorta...
Includes: Supplementary data
Articles
Yanan Liu, Shaoqing Lei, Xia Gao, Xiaowen Mao, Tingting Wang, Gordon T. Wong, Paul M. Vanhoutte, Michael G. Irwin, Zhengyuan Xia
Journal:
Clinical Science
Clin Sci (Lond) (2012) 122 (4): 161–173.
Published: 14 October 2011
... The Authors Journal compilation © 2012 Biochemical Society 2012 diabetic cardiomyopathy left ventricular hypertrophy oxidative stress protein kinase Cβ ruboxistaurin Diabetic cardiomyopathy, mainly manifested as LVH [LV (left ventricular) hypertrophy] and dysfunction, ultimately leads...
Articles
Giovanna Castoldi, Cira R. T. Di Gioia, Camila Bombardi, Carla Perego, Lucia Perego, Massimiliano Mancini, Martina Leopizzi, Barbara Corradi, Stefano Perlini, Gianpaolo Zerbini, Andrea Stella
Journal:
Clinical Science
Clin Sci (Lond) (2010) 118 (3): 211–220.
Published: 01 February 2010
... (angiotensin-converting enzyme). In experimental models of hypertension, Ac-SDKP has antifibrotic effects in the heart; however, the role of Ac-SDKP in diabetic cardiomyopathy is currently unknown. The aim of the present study was to evaluate the effect of Ac-SDKP on cardiac systolic and diastolic function...
Articles
Omar Asghar, Ahmed Al-Sunni, Kaivan Khavandi, Ali Khavandi, Sarah Withers, Adam Greenstein, Anthony M. Heagerty, Rayaz A. Malik
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (10): 741–760.
Published: 15 April 2009
...Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M. Heagerty; Rayaz A. Malik Diabetic cardiomyopathy is a distinct primary disease process, independent of coronary artery disease, which leads to heart failure in diabetic patients. Epidemiological...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2004) 107 (6): 539–557.
Published: 24 November 2004
... with heart failure. This suggests that there is an urgent need to conduct pathogenetic, diagnostic and therapeutic studies specifically in diabetic patients with cardiomyopathy to better understand the factors which initiate and progress diabetic cardiomyopathy and to develop more effective treatments...